TY  - JOUR
T1  - CHildren’s exposure to testosterone gel spurs fda to order boxed label warning
AU  - Voelker R
Y1  - 2009/06/17
N1  - 10.1001/jama.2009.810
JO  - JAMA
SP  - 2428
EP  - 2428
VL  - 301
IS  - 23
N2  - 
The gels are approved for use in men who produce little or no testosterone. They are applied topically to the shoulders or upper arms; AndroGel 1% is approved for application to the abdomen. Current label instructions advise patients to wash their hands and cover the treated area with clothing after using the product. The FDA noted that most cases of adverse events in children occurred because patients failed to follow the label instructions, resulting in skin-to-skin contact with a child.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.810
UR  - http://dx.doi.org/10.1001/jama.2009.810
ER  -